Immunology and Microbiology
Human Cytomegalovirus
100%
Cytomegalovirus
97%
Cytomegalovirus Infection
87%
Antibody Response
52%
Monospecific Antibody
50%
T Cell
48%
Transplant Procedure
46%
Western Blot
43%
Vaccine Efficacy
40%
Dendritic Cell
40%
Viral Load
38%
Enzyme-Linked Immunosorbent Assay
32%
Monoclonal Antibody
30%
Molecular Weight
30%
Wart Virus
30%
DNA Binding Protein
27%
Humoral Immunity
25%
Early Antigen
24%
Adoptive Immunity
24%
Virus Antigen
23%
Immunotherapy
22%
Epithelial Cell Adhesion Molecule
20%
Cervarix
20%
Allotransplantation
20%
Chemical Structure
20%
Surface Property
20%
Macrophage Activation
20%
Replicon
20%
Transgenic Mouse
20%
Lung Transplantation
20%
Normal Human
20%
Cancer Vaccine
20%
Macrophage
20%
Virus Particle
20%
Recombinant Antigen
20%
Membrane Antigen
20%
Adalimumab
20%
Human Papillomavirus Type 16
18%
Semliki Forest Virus
18%
Cytotoxic T-Cell
18%
Epitope
18%
Matrix Protein
18%
Immune Response
16%
T-Helper Cell
16%
Immunoglobulin M
13%
ELISA
13%
CD4
13%
Fibroblast
12%
CD8
11%
Vaccination Policy
10%
Keyphrases
Good Manufacturing Practice
53%
Parenteral Drug Products
40%
Pharmacy Compounding
40%
Qualification Test
40%
Practice Conditions
40%
Hospital Pharmacy
40%
Visual Inspection
40%
Inspection Technique
40%
Cytomegalovirus
25%
System Generations
20%
T Cell Response
20%
Surface Free Energy
20%
Polyurethane Coating
20%
Macrophage Function
20%
Long-term Function
20%
Fluorinated Polyurethane
20%
Dendritic Cells
20%
Encapsulated Cell Therapy
20%
Apoptotic Cells
20%
Biocompatibility
20%
Long-term Biocompatibility
20%
Pancreatic Islets
20%
Viral Antigens
20%
Fusion Protein
20%
Immunoblot Analysis
20%
Partially Overlapped
20%
Recombinant Fusion Proteins
20%
Cancer Vaccine
20%
First-in-human
20%
High-risk Human Papillomavirus (HR-HPV)
20%
Immunization
20%
Phase I Clinical Trial
20%
RNA Replicon
20%
Clinical Grade
20%
Cell Therapy
20%
Parotid Salivary Gland
20%
Head-and-neck Cancer
20%
Tumor Neoantigens
20%
Radiation-induced Xerostomia
20%
Salivary Gland Organoids
20%
Production Process
20%
Pharmaceutics
20%
Academic Editor
20%
Salivary Gland
13%
Manufacturing Process
13%
Immature Dendritic Cells
11%
T Cells
10%
P-p65
10%
Encapsulated Islets
10%
Immunoprotective Effect
10%
Pharmacology, Toxicology and Pharmaceutical Science
Good Manufacturing Practice
76%
Neoplasm
45%
Hospital Pharmacy
40%
Human Papillomavirus
30%
Malignant Neoplasm
29%
Clinical Trial
27%
Fusion Protein
25%
Cancer Vaccine
22%
Wart Virus Vaccine
20%
Monoclonal Antibody
20%
Cytomegalovirus
20%
Transgenic Mouse
20%
Xerostomia
20%
Western Blot
20%
Head and Neck Cancer
20%
Biodistribution
20%
Non Small Cell Lung Cancer
20%
Epithelial Cell Adhesion Molecule
20%
Phase II Trials
20%
Biocompatibility
20%
Guanosine Phosphate
20%
Pharmaceutics
20%
Semliki Forest Virus
18%
Human Papillomavirus Type 16
18%
Therapeutic Vaccine
14%
CD8 Antigen
13%
Epileptic Absence
11%
Disease
9%
Phase I Trials
6%
Amylase
6%
Interferon
6%
Tolerability
6%
Alphavirus
6%
Hyposalivation
6%
Uterine Cervix Carcinoma in Situ
6%
Phosphoprotein
6%
Injection Site Reaction
6%
Insulin Dependent Diabetes Mellitus
6%
DNA Binding Protein
6%
Mouse
6%
Protein E6
5%
Protein E7
5%
Vaccination Policy
5%
Preclinical Study
5%
Immunogenicity
5%
Endotoxin
5%
Primary Tumor
5%
Metastasis
5%
Biological Activity
5%
